ARQT Company Profile and Key Details

Q: Who are the executives of ARQT?

Mr. Kenneth A. LockSenior Vice President & Chief Commercial OfficerDr. David W. Osborne Ph.D.Chief Technical OfficerMr. Matthew Richard MooreSenior Vice President & Chief Bus. OfficerMr. Scott L. BurrowsChief Financial Officer, Principal Accounting Officer & Senior Vice PresidentMr. Rajvir MadanChief Digital & Technology OfficerMs. Kimberly LathroumVice President of MarketingMr. Todd Franklin Watanabe M.A.Pres, Chief Executive Officer & DirectorDr. Bhaskar Chaudhuri Ph.D.Co-Founder & Independent DirectorDr. Patrick E. Burnett M.D., Ph.D.Senior Vice President & Chief Medical OfficerMr. Eric McIntyreHead of Investor RelationsMs. Courtney BartonVice President and Chief Compliance Officer & Privacy OfficerMs. Amanda SheldonHead of Corporation CommunicationsMr. Masaru Matsuda Esq., J.D.Senior Vice President, Gen. Counsel & Corporation Sec.Ms. Patricia A. TurneySenior Vice President of Operations

NASDAQ : ARQT

Arcutis Biotherapeutics

$26.07

-0.01-0.04%

At Close 4:00 PM

71.67

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Arcutis Biotherapeutics, Inc. (ARQT) stock declined over -0.04%, trading at $26.07 on NASDAQ, down from the previous close of $26.08. The stock opened at $26.18, fluctuating between $25.96 and $26.72 in the recent session.

Stock Snapshot

26.08

Prev. Close

3.19B

Market Cap

25.96

Day Low

-76.68

P/E Ratio

-0.34

EPS (TTM)

-2.67

Cash Flow per Share

26.18

Open

122.49M

Number of Shares

26.72

Day High

87.32%

Free Float in %

0.96

Book Value

1.51M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	26.18	26.73	25.96	26.07	1.54M
Feb 04, 2026	26.06	26.21	25.58	26.08	2.3M
Feb 03, 2026	25.43	26.67	25.03	26.19	979.8K
Feb 02, 2026	25.03	25.75	24.50	25.57	1.44M
Jan 30, 2026	25.37	25.63	24.96	25.37	929.04K
Jan 29, 2026	25.29	25.95	25.22	25.73	1.25M
Jan 28, 2026	26.19	26.39	25.40	25.45	741.8K
Jan 27, 2026	26.32	26.97	26.01	26.33	745.45K
Jan 26, 2026	25.80	26.62	25.51	26.32	1.11M
Jan 23, 2026	26.41	26.90	26.09	26.20	1.11M
Jan 22, 2026	26.69	27.08	26.18	26.65	1.7M
Jan 21, 2026	25.74	26.75	25.57	26.70	1.74M
Jan 20, 2026	25.32	26.00	25.12	25.87	992.06K
Jan 16, 2026	26.49	26.63	25.80	25.85	1.09M
Jan 15, 2026	26.65	26.89	25.99	26.36	1.1M
Jan 14, 2026	25.85	26.93	25.77	26.73	1.29M
Jan 13, 2026	26.69	26.78	25.35	26.05	2.02M
Jan 12, 2026	27.75	28.10	25.45	26.78	3.63M
Jan 09, 2026	30.01	30.75	28.11	28.22	1.75M
Jan 08, 2026	29.18	30.26	28.86	29.88	1.7M

Contact Details

Westlake Village, CA 91361

United States

https://www.arcutis.com 805 418 5006

About Company

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Stock Peers

ARGX

-30.56-3.59%

argenx SE$820.31 REGN

-8.645-1.12%

Regeneron Pharmaceuticals, Inc.$766.63 UTHR

-3.66-0.76%

United Therapeutics Corporation$478.93 MDGL

-15.19-3.17%

Madrigal Pharmaceuticals, Inc.$463.42 VRTX

-11.71-2.49%

Vertex Pharmaceuticals Incorporated$458.81 ALNY

-20.72-5.89%

Alnylam Pharmaceuticals, Inc.$331.24 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

2.28+0.75%

Praxis Precision Medicines, Inc.$305.62 KRYS

-1.49-0.55%

Krystal Biotech, Inc.$267.64 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Arcutis Biotherapeutics, Inc. (ARQT) stock price?

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) stock price is $26.07 in the last trading session. During the trading session, ARQT stock reached the peak price of $26.72 while $25.96 was the lowest point it dropped to. The percentage change in ARQT stock occurred in the recent session was -0.04% while the dollar amount for the price change in ARQT stock was - $0.01.

ARQT's industry and sector of operation?

The NASDAQ listed ARQT is part of Biotechnology industry that operates in the broader Healthcare sector. Arcutis Biotherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ARQT?

Mr. Kenneth A. Lock
Senior Vice President & Chief Commercial Officer
Dr. David W. Osborne Ph.D.
Chief Technical Officer
Mr. Matthew Richard Moore
Senior Vice President & Chief Bus. Officer
Mr. Scott L. Burrows
Chief Financial Officer, Principal Accounting Officer & Senior Vice President
Mr. Rajvir Madan
Chief Digital & Technology Officer
Ms. Kimberly Lathroum
Vice President of Marketing
Mr. Todd Franklin Watanabe M.A.
Pres, Chief Executive Officer & Director
Dr. Bhaskar Chaudhuri Ph.D.
Co-Founder & Independent Director
Dr. Patrick E. Burnett M.D., Ph.D.
Senior Vice President & Chief Medical Officer
Mr. Eric McIntyre
Head of Investor Relations
Ms. Courtney Barton
Vice President and Chief Compliance Officer & Privacy Officer
Ms. Amanda Sheldon
Head of Corporation Communications
Mr. Masaru Matsuda Esq., J.D.
Senior Vice President, Gen. Counsel & Corporation Sec.
Ms. Patricia A. Turney
Senior Vice President of Operations

How ARQT did perform over past 52-week?

ARQT's closing price is 134.23% higher than its 52-week low of $11.13 where as its distance from 52-week high of $31.77 is -17.94%.

How many employees does ARQT have?

Number of ARQT employees currently stands at 342.

Link for ARQT official website?

Official Website of ARQT is: https://www.arcutis.com

How do I contact ARQT?

ARQT could be contacted at phone 805 418 5006 and can also be accessed through its website. ARQT operates from 3027 Townsgate Road, Westlake Village, CA 91361, United States.

How many shares of ARQT are traded daily?

ARQT stock volume for the day was 1.51M shares. The average number of ARQT shares traded daily for last 3 months was 1.98M.

What is the market cap of ARQT currently?

The market value of ARQT currently stands at $3.19B with its latest stock price at $26.07 and 122.49M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	342
Beta	1.72
Sales or Revenue	$59.61M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	342
Beta	1.72
Sales or Revenue	$59.61M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ARQT Company Profile and Key Details

Arcutis Biotherapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics